The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A pilot study of neoadjuvant FOLFIRINOX followed by chemoradiation for gastric and gastroesophageal cancer: Preliminary results.
 
Jennifer Yon-Li Wo
No Relationships to Disclose
 
Jeffrey William Clark
Consulting or Advisory Role - Emas pharma
Research Funding - Pfizer (Inst)
 
Jill N. Allen
No Relationships to Disclose
 
Lawrence Scott Blaszkowsky
Stock and Other Ownership Interests - Pfizer (I)
 
Florence Keane
No Relationships to Disclose
 
Lorraine C. Drapek
No Relationships to Disclose
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; MPM Capital
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; MPM Capital; Oncorus
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Other Relationship - TCR2 Therapeutics
 
Ryan Bruce Corcoran
Stock and Other Ownership Interests - Avidity Biosciences; nRichDx
Consulting or Advisory Role - Amgen; Array BioPharma; Astex Pharmaceuticals; Avidity Nanomedicines; Bristol-Myers Squibb; Chugai Pharma; FOGPharma; Genentech; Loxo; Merrimack; N-of-One; nRichDx; Roche; Roivant; Shire; Spectrum Pharmaceuticals; Symphogen; Taiho Pharmaceutical; Warp Drive Bio
Research Funding - AstraZeneca; Sanofi
 
Eric Roeland
Consulting or Advisory Role - AIM Specialty Health; BASF; Helsinn Healthcare (Inst); Immuneering; Napo Pharmaceuticals; Oragenics; Pronova (Inst)
 
Aparna Raj Parikh
Consulting or Advisory Role - Driver, Inc; Eisai; Foundation Medicine; PureTech
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); OncoMed (Inst); Plexxikon (Inst); Tolero Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Eisai
 
Melin Janardan Khandekar
No Relationships to Disclose
 
Rebecca Suk Heist
Consulting or Advisory Role - Apollomics; Boehringer Ingelheim; Novartis; Tarveda Therapeutics
Research Funding - Abbvie (Inst); Agios (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); Exelixis (Inst); Exelixis (Inst); Incyte (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst); Pfizer (Inst); Roche (Inst)
 
Christopher Morse
No Relationships to Disclose
 
Beow Y. Yeap
Consulting or Advisory Role - Abcodia (I)
 
Christine A Ulysse
No Relationships to Disclose
 
Benjamin Christopher
No Relationships to Disclose
 
Michael Lanuti
Honoraria - Emory University; Holy Cross Hospital
Research Funding - NIH; NIH; Stand up to Cancer
 
David L. Berger
No Relationships to Disclose
 
John Thomas Mullen
No Relationships to Disclose
 
Theodore S. Hong
Consulting or Advisory Role - Clinical Genomics; EMD Serono
Research Funding - AstraZeneca (Inst); clinical genomics (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)